Quarterly Results

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE584.5010.9 (+1.9 %)
PREV CLOSE ( ) 573.60
OPEN PRICE ( ) 564.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 49552
TODAY'S LOW / HIGH ( )554.40 594.00
52 WK LOW / HIGH ( )165.2 630
NSE582.859.9 (+1.73 %)
PREV CLOSE( ) 572.95
OPEN PRICE ( ) 560.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 582.85 (125)
VOLUME 507393
TODAY'S LOW / HIGH( ) 558.95 594.70
52 WK LOW / HIGH ( )165 630
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
7010
7530
6440
6780
Total Expenditure
6640
6810
6280
6750
PBIDT (Excl OI)
370
720
160
30
Other Income
80
240
140
320
Operating Profit
450
960
300
350
Interest
770
760
790
760
Exceptional Items
NA
0.00
-140
-960
PBDT
-320
200
-630
-1370
Depreciation
550
550
550
560
Profit Before Tax
-870
-350
-1180
-1930
Tax
-10
380
180
440
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-860
-730
-1360
-2370
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-860
-730
-1360
-2370
Minority Interest
30
-40
20
290
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-830
-770
-1340
-2080
Equity Capital
720
720
720
720
Face Value (IN RS)
5
5
5
5
Reserves
NA
NA
NA
NA
Calculated EPS
-5.76
-5.34
-9.30
-14.44
Calculated EPS (Annualised)
-23.05
-21.38
-37.22
-57.77
No of Public Share Holdings
64945397
64638497
59938497
58632247
% of Public Share Holdings
45.07
44.86
41.6
40.69
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
5.27
9.56
2.48
0.44
PBIDTM%
6.41
12.74
4.65
5.16
PBDTM%
-4.56
2.65
-9.78
-20.20
PBTM%
-12.41
-4.64
-18.32
-28.46
PATM%
-12.26
-9.69
-21.11
-34.95
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.